Welcure Drugs & Pharmaceuticals Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 29/05/2025 ,inter alia, to consider and approve 1. To consider ....
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Welcure Drugs & Pharmaceuticals has informed BSE that its Board of Directors will meet on Thursday, 29th May 2025 at the registered office. The main agenda is to consider and approve the Audited Financial Results for the quarter and full year ended 31st March 2025. The board will also take on record the Audit Report of the Statutory Auditors and approve the audited financial statements, including the Balance Sheet, Statement of Profit and Loss, Cash Flow Statement, and Statement of Changes in Equity for FY 2024-25. Additionally, the board will consider appointing Vishakha Agrawal & Associates, Practicing Company Secretaries, as the Secretarial Auditor of the company for FY 2024-25. The trading window for the company's shares has already been closed since 1st April 2025 in line with insider trading norms.
This is a routine pre-results intimation with no actual numbers disclosed yet. Shareholders should wait for the audited results on 29th May 2025 to gauge full-year performance, profitability, and any dividend or other corporate action announcements.